| GRSRX | NGJCX | GRSRX / NGJCX | |
| Total Expense Ratio | 1.34 | 2.05 | 65% |
| Annual Report Gross Expense Ratio | 1.34 | 2.64 | 51% |
| Fund Existence | 12 years | 8 years | - |
| Gain YTD | 7.127 | 7.360 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.28B | 27.2M | 8,393% |
| Annual Yield % from dividends | 2.66 | 2.10 | 127% |
| Returns for 1 year | 10.22 | 10.40 | 98% |
| Returns for 3 years | 31.93 | 30.06 | 106% |
| Returns for 5 years | 4.48 | -5.60 | -80% |
| Returns for 10 years | 50.19 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 88.01 | 2.99 | +3.51% |
| ProShares Ultra Nasdaq Biotechnology | |||
| TEQI | 50.36 | 0.17 | +0.34% |
| T. Rowe Price Equity Income ETF | |||
| ACWV | 119.25 | -0.04 | -0.03% |
| iShares MSCI Global Min Vol Factor ETF | |||
| CBOJ | 23.66 | -0.02 | -0.06% |
| Calamos Bitcoin Str Alt Prt ETF-Jan | |||
| CPNJ | 27.61 | -0.02 | -0.07% |
| Calamos Nasdaq-100 Str Alt Prt ETF-Jun | |||